This expansion will provide the potential for BIO-CAT Microbials to grow its current fermentation production by more than 400%.
Blue Knight is a collaborative program designed to anticipate and respond to global health security threats.
VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region
Funding will further Charlottesville BioHub’s goals to advance entrepreneurship in the area’s biotechnology sector and support tech and other innovation-led sectors with resourcing and connection.
ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin
First-in-human, open-label, dose escalation study will evaluate ZB131 in patients who have solid tumors with high CSP expression.
The net proceeds of the offering strengthen Adial’s balance sheet as it moves toward completion of the Company’s Phase 3 ONWARD™ trial.
RIVANNA® expands world-class engineering team to advance development of the Accuro® Product Platform
As a domain expert in applications of diagnostic ultrasound imaging, Dr. Sheeran will lead projects primarily focused on Accuro XV CADe/x algorithm development and testing at RIVANNA.
Adial Pharmaceuticals Receives Notice of Allowance on the U.S. Patent for the Treatment for Opioid Use Disorder Using AD04
Patent covers patients with a specific genetic biomarker for the serotonin-3 receptor.
Bonumose's Low-Cost Tagatose Process Receives Key Health Agency Approvals, Construction of First Production Facility on Schedule for Spring 2022 Opening
ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant.